Cumberland Pharmaceuticals Inc. Operating Income
Cumberland Pharmaceuticals Inc. (CPIX) reported Operating Income of -$3.16 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-07
- Cumberland Pharmaceuticals Inc. operating income (loss) for the quarter ending 2026-06-30 was -$3.16M.
- Cumberland Pharmaceuticals Inc. operating income (loss) for the quarter ending 2026-03-31 was -$3.13M, a 342.22% decline year-over-year.
- Cumberland Pharmaceuticals Inc. operating income (loss) for the quarter ending 2025-12-31 was -$1.37M.
- Cumberland Pharmaceuticals Inc. operating income (loss) for the quarter ending 2025-09-30 was -$1.97M.
- Cumberland Pharmaceuticals Inc. operating income (loss) for fiscal 2025 was -$2.79M.
- Cumberland Pharmaceuticals Inc. operating income (loss) for fiscal 2024 was -$6.43M.
- Cumberland Pharmaceuticals Inc. operating income (loss) for fiscal 2023 was -$9.55M.
- Cumberland Pharmaceuticals Inc. operating income (loss) for fiscal 2022 was -$5.70M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.16M 10-Q · filed 2026-08-07 | -$6.09M 10-Q · filed 2026-08-07 | -$7.66M derived: sum of 3 quarters · filed 2026-08-07 | -$9.63M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | -$3.13M 10-Q · filed 2026-05-08 | -$4.50M derived: sum of 2 quarters · filed 2026-05-08 | -$6.47M derived: sum of 3 quarters · filed 2026-05-08 | -$9.59M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | -$1.37M 10-K · filed 2026-03-09 | -$3.34M derived: sum of 2 quarters · filed 2026-03-09 | -$6.46M derived: sum of 3 quarters · filed 2026-08-07 | -$2.79M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | -$1.97M 10-K · filed 2026-03-09 | -$5.08M derived: sum of 2 quarters · filed 2026-08-07 | -$1.42M 10-Q · filed 2025-11-07 | -$5.63M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | -$3.12M 10-Q · filed 2026-08-07 | -$747.48K 10-Q · filed 2025-08-08 | -$5.84M 10-Q · filed 2026-08-07 | $544.47K 10-Q · filed 2025-08-08 | -$3.67M derived: sum of 3 quarters · filed 2026-08-07 | -$5.36M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $1.29M 10-Q · filed 2026-05-08 | -$550.09K derived: sum of 2 quarters · filed 2026-05-08 | -$2.24M derived: sum of 3 quarters · filed 2026-05-08 | -$3.27M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | -$1.84M 10-K · filed 2026-03-09 | -$3.54M derived: sum of 2 quarters · filed 2026-03-09 | -$4.56M derived: sum of 3 quarters · filed 2026-03-09 | -$6.43M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | -$1.69M 10-K · filed 2026-03-09 | -$2.72M derived: sum of 2 quarters · filed 2026-03-09 | -$4.59M 10-Q · filed 2025-11-07 | -$10.77M derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2024-06-30 | -$1.03M 10-K · filed 2026-03-09 | -$2.90M 10-Q · filed 2025-08-08 | -$9.08M derived: sum of 3 quarters · filed 2026-03-09 | -$10.94M derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2024-03-31 | -$1.87M 10-K · filed 2026-03-09 | -$8.05M derived: sum of 2 quarters · filed 2026-03-09 | -$9.92M derived: sum of 3 quarters · filed 2026-03-09 | -$9.89M derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2023-12-31 | -$6.18M 10-K · filed 2025-03-07 | -$8.05M derived: sum of 2 quarters · filed 2025-03-07 | -$8.02M derived: sum of 3 quarters · filed 2025-03-07 | -$9.55M 10-K · filed 2025-03-07 | ||||
| 2023-09-30 | -$1.87M 10-K · filed 2025-03-07 | -$1.84M derived: sum of 2 quarters · filed 2025-03-07 | -$3.38M 10-Q · filed 2024-11-08 | -$5.65M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-06-30 | $22.86K 10-K · filed 2025-03-07 | -$1.51M 10-Q · filed 2024-08-09 | -$3.79M derived: sum of 3 quarters · filed 2025-03-07 | -$4.08M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-03-31 | -$1.53M 10-K · filed 2025-03-07 | -$3.81M derived: sum of 2 quarters · filed 2025-03-07 | -$4.10M derived: sum of 3 quarters · filed 2025-03-07 | -$5.94M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2022-12-31 | -$2.28M 10-K · filed 2024-03-13 | -$2.57M derived: sum of 2 quarters · filed 2024-03-13 | -$4.41M derived: sum of 3 quarters · filed 2024-03-13 | -$5.70M 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | -$288.59K 10-K · filed 2024-03-13 | -$2.14M derived: sum of 2 quarters · filed 2024-03-13 | -$3.43M 10-Q · filed 2023-11-13 | -$7.78M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-06-30 | -$1.85M 10-K · filed 2024-03-13 | -$3.14M 10-Q · filed 2023-08-11 | -$7.49M derived: sum of 3 quarters · filed 2024-03-13 | -$9.06M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-03-31 | -$1.29M 10-K · filed 2024-03-13 | -$5.65M derived: sum of 2 quarters · filed 2024-03-13 | -$7.21M derived: sum of 3 quarters · filed 2024-03-13 | -$8.65M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2021-12-31 | -$4.35M 10-K · filed 2023-03-13 | -$5.92M derived: sum of 2 quarters · filed 2023-03-13 | -$7.35M derived: sum of 3 quarters · filed 2023-03-13 | -$7.68M 10-K · filed 2023-03-13 | ||||
| 2021-09-30 | -$1.56M 10-K · filed 2023-03-13 | -$3.00M derived: sum of 2 quarters · filed 2023-03-13 | -$3.32M 10-Q · filed 2022-11-14 | -$5.07M derived: sum of 4 quarters · filed 2023-03-13 | ||||
| 2021-06-30 | -$1.44M 10-K · filed 2023-03-13 | -$1.76M 10-Q · filed 2022-08-12 | -$3.51M derived: sum of 3 quarters · filed 2023-03-13 | -$4.71M derived: sum of 4 quarters · filed 2023-03-13 | ||||
| 2021-03-31 | -$324.30K 10-K · filed 2023-03-13 | -$2.07M derived: sum of 2 quarters · filed 2023-03-13 | -$3.28M derived: sum of 3 quarters · filed 2023-03-13 | -$4.86M derived: sum of 4 quarters · filed 2023-03-13 | ||||
| 2020-12-31 | -$1.75M 10-K · filed 2022-03-11 | -$2.95M derived: sum of 2 quarters · filed 2022-03-11 | -$4.54M derived: sum of 3 quarters · filed 2022-03-11 | -$6.38M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | -$1.21M 10-K · filed 2022-03-11 | -$2.79M derived: sum of 2 quarters · filed 2022-03-11 | -$4.64M 10-Q · filed 2021-11-12 | -$4.64M 10-Q · filed 2020-11-13 | -$8.03M derived: sum of 4 quarters · filed 2022-03-11 | |||
| 2020-06-30 | -$1.58M 10-K · filed 2022-03-11 | -$3.43M 10-Q · filed 2021-08-13 | -$6.82M derived: sum of 3 quarters · filed 2022-03-11 | -$10.02M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-03-31 | -$1.85M 10-K · filed 2022-03-11 | -$5.24M derived: sum of 2 quarters · filed 2022-03-11 | -$8.44M derived: sum of 3 quarters · filed 2022-03-11 | -$9.81M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2019-12-31 | -$3.39M 10-K · filed 2021-03-12 | -$997.41K 10-K · filed 2020-03-20 | -$6.59M derived: sum of 2 quarters · filed 2021-03-12 | -$7.96M derived: sum of 3 quarters · filed 2021-03-12 | -$9.29M 10-K · filed 2022-03-11 | -$3.62M 10-K · filed 2020-03-20 | ||
| 2019-09-30 | -$3.20M 10-K · filed 2021-03-12 | -$1.85M 10-Q · filed 2019-11-13 | -$4.57M derived: sum of 2 quarters · filed 2021-03-12 | -$5.89M 10-Q · filed 2020-11-13 | -$2.63M 10-Q · filed 2019-11-13 | -$9.19M derived: sum of 4 quarters · filed 2021-03-12 | ||
| 2019-06-30 | -$1.37M 10-K · filed 2021-03-12 | -$601.72K 10-Q · filed 2019-08-14 | -$2.70M 10-Q · filed 2020-08-14 | -$778.51K 10-Q · filed 2019-08-14 | -$5.99M derived: sum of 3 quarters · filed 2021-03-12 | -$8.64M derived: sum of 4 quarters · filed 2021-03-12 | ||
| 2019-03-31 | -$1.32M 10-K · filed 2021-03-12 | -$176.80K 10-Q · filed 2019-05-15 | -$4.62M derived: sum of 2 quarters · filed 2021-03-12 | -$7.26M derived: sum of 3 quarters · filed 2021-03-12 | -$9.18M derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2018-12-31 | -$3.29M 8-K · filed 2020-12-10 | -$2.26M 10-K · filed 2019-03-12 | -$5.94M derived: sum of 2 quarters · filed 2020-12-10 | -$7.86M derived: sum of 3 quarters · filed 2020-12-10 | -$11.17M 10-K · filed 2021-03-12 | -$7.39M 10-K · filed 2019-03-12 | ||
| 2018-09-30 | -$2.64M 8-K · filed 2020-12-10 | -$1.81M 10-Q · filed 2018-11-14 | -$4.56M derived: sum of 2 quarters · filed 2020-12-10 | -$5.13M 10-Q · filed 2019-11-13 | -$8.78M derived: sum of 4 quarters · filed 2020-12-10 | |||
| 2018-06-30 | -$1.92M 8-K · filed 2020-12-10 | -$868.98K 10-Q · filed 2018-08-14 | -$3.32M 10-Q · filed 2019-08-14 | -$6.14M derived: sum of 3 quarters · filed 2020-12-10 | -$6.98M derived: sum of 4 quarters · filed 2020-12-10 | |||
| 2018-03-31 | -$3.32M 8-K · filed 2020-12-10 | -$2.45M 10-Q · filed 2018-05-09 | -$4.22M derived: sum of 2 quarters · filed 2020-12-10 | -$5.06M derived: sum of 3 quarters · filed 2020-12-10 | -$6.74M derived: sum of 4 quarters · filed 2020-12-10 | |||
| 2017-12-31 | -$903.33K 10-K · filed 2019-03-12 | -$1.74M derived: sum of 2 quarters · filed 2019-03-12 | -$3.42M derived: sum of 3 quarters · filed 2019-03-12 | -$8.88M 8-K · filed 2020-12-10 | -$4.08M 10-K · filed 2018-03-09 | |||
| 2017-09-30 | -$839.35K 10-K · filed 2019-03-12 | -$2.52M derived: sum of 2 quarters · filed 2019-03-12 | -$3.18M 10-Q · filed 2018-11-14 | -$4.14M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2017-06-30 | -$1.68M 10-K · filed 2019-03-12 | -$2.34M 10-Q · filed 2018-08-14 | -$3.30M derived: sum of 3 quarters · filed 2019-03-12 | -$3.17M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2017-03-31 | -$657.80K 10-K · filed 2019-03-12 | -$1.62M derived: sum of 2 quarters · filed 2019-03-12 | -$1.49M derived: sum of 3 quarters · filed 2019-03-12 | -$1.59M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2016-12-31 | -$957.37K 10-K · filed 2018-03-09 | -$827.24K derived: sum of 2 quarters · filed 2018-03-09 | -$932.55K derived: sum of 3 quarters · filed 2018-03-09 | -$1.43M 10-K · filed 2019-03-12 | ||||
| 2016-09-30 | $130.13K 10-K · filed 2018-03-09 | $24.82K derived: sum of 2 quarters · filed 2018-03-09 | -$475.76K 10-Q · filed 2017-11-08 | -$313.08K derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-06-30 | -$105.31K 10-K · filed 2018-03-09 | -$605.89K 10-Q · filed 2017-08-09 | -$443.21K derived: sum of 3 quarters · filed 2018-03-09 | -$172.33K derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-03-31 | -$500.58K 10-K · filed 2018-03-09 | -$337.90K derived: sum of 2 quarters · filed 2018-03-09 | -$67.02K derived: sum of 3 quarters · filed 2018-03-09 | $606.91K derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2015-12-31 | $162.68K 10-K · filed 2017-03-13 | $433.56K derived: sum of 2 quarters · filed 2017-03-13 | $1.11M derived: sum of 3 quarters · filed 2017-03-13 | $1.11M 10-K · filed 2018-03-09 | ||||
| 2015-09-30 | $270.88K 10-K · filed 2017-03-13 | $944.82K derived: sum of 2 quarters · filed 2017-03-13 | $948.93K 10-Q · filed 2016-11-03 | $1.90M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2015-06-30 | $673.93K 10-K · filed 2017-03-13 | $678.05K 10-Q · filed 2016-08-05 | $1.62M derived: sum of 3 quarters · filed 2017-03-13 | $2.61M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2015-03-31 | $4.12K 10-K · filed 2017-03-13 | $950.25K derived: sum of 2 quarters · filed 2017-03-13 | $1.94M derived: sum of 3 quarters · filed 2017-03-13 | $3.15M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2014-12-31 | $946.14K 10-K · filed 2016-03-14 | $1.94M derived: sum of 2 quarters · filed 2016-03-14 | $3.15M derived: sum of 3 quarters · filed 2016-03-14 | $3.56M 10-K · filed 2017-03-13 | ||||
| 2014-09-30 | $989.04K 10-K · filed 2016-03-14 | $2.20M derived: sum of 2 quarters · filed 2016-03-14 | $2.61M 10-Q · filed 2015-11-06 | $140.62K derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-06-30 | $1.22M 10-K · filed 2016-03-14 | $1.62M 10-Q · filed 2015-08-07 | -$848.42K derived: sum of 3 quarters · filed 2016-03-14 | -$2.36M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-03-31 | $408.05K 10-K · filed 2016-03-14 | -$2.06M derived: sum of 2 quarters · filed 2016-03-14 | -$3.58M derived: sum of 3 quarters · filed 2016-03-14 | -$4.72M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2013-12-31 | -$2.47M 10-K · filed 2015-03-09 | -$3.99M derived: sum of 2 quarters · filed 2015-03-09 | -$5.13M derived: sum of 3 quarters · filed 2015-03-09 | -$3.80M 10-K · filed 2016-03-14 | ||||
| 2013-09-30 | -$1.51M 10-K · filed 2015-03-09 | -$2.66M derived: sum of 2 quarters · filed 2015-03-09 | -$1.33M 10-Q · filed 2014-11-07 | $1.92M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-06-30 | -$1.14M 10-K · filed 2015-03-09 | $185.51K 10-Q · filed 2014-08-08 | $3.44M derived: sum of 3 quarters · filed 2015-03-09 | $6.42M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-03-31 | $1.33M 10-K · filed 2015-03-09 | $4.58M derived: sum of 2 quarters · filed 2015-03-09 | $7.56M derived: sum of 3 quarters · filed 2015-03-09 | $9.50M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2012-12-31 | $3.25M 10-K · filed 2014-03-11 | $6.23M derived: sum of 2 quarters · filed 2014-03-11 | $8.17M derived: sum of 3 quarters · filed 2014-03-11 | $8.82M 10-K · filed 2015-03-09 | ||||
| 2012-09-30 | $2.98M 10-K · filed 2014-03-11 | $4.92M derived: sum of 2 quarters · filed 2014-03-11 | $5.57M 10-Q · filed 2013-11-06 | $7.28M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-06-30 | $1.94M 10-K · filed 2014-03-11 | $2.59M 10-Q · filed 2013-08-09 | $4.30M derived: sum of 3 quarters · filed 2014-03-11 | $7.40M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-03-31 | $646.01K 10-K · filed 2014-03-11 | $2.36M derived: sum of 2 quarters · filed 2014-03-11 | $5.46M derived: sum of 3 quarters · filed 2014-03-11 | $9.09M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2011-12-31 | $1.71M 10-K · filed 2013-03-12 | $4.81M derived: sum of 2 quarters · filed 2013-03-12 | $8.44M derived: sum of 3 quarters · filed 2013-03-12 | $9.85M 10-K · filed 2014-03-11 | ||||
| 2011-09-30 | $3.10M 10-K · filed 2013-03-12 | $6.73M derived: sum of 2 quarters · filed 2013-03-12 | $8.14M 10-Q · filed 2012-11-02 | $10.38M derived: sum of 4 quarters · filed 2013-03-12 | ||||
| 2011-06-30 | $3.63M 10-K · filed 2013-03-12 | $5.04M 10-Q · filed 2012-08-09 | $7.28M derived: sum of 3 quarters · filed 2013-03-12 | $9.72M derived: sum of 4 quarters · filed 2013-03-12 | ||||
| 2011-03-31 | $1.41M 10-K · filed 2013-03-12 | $3.65M derived: sum of 2 quarters · filed 2013-03-12 | $6.09M derived: sum of 3 quarters · filed 2013-03-12 | $7.10M derived: sum of 4 quarters · filed 2013-03-12 | ||||
| 2010-12-31 | $2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $4.68M derived: sum of 2 quarters · filed 2013-03-12 | $5.69M derived: sum of 3 quarters · filed 2013-03-12 | $6.50M 10-K · filed 2013-03-12 | ||||
| 2010-09-30 | $2.44M 10-Q · filed 2011-11-07 | $3.45M derived: sum of 2 quarters · filed 2011-11-07 | $4.26M 10-Q · filed 2011-11-07 | |||||
| 2010-06-30 | $1.01M 10-Q · filed 2011-08-08 | $1.82M 10-Q · filed 2011-08-08 | ||||||
| 2009-12-31 | $5.78M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |